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Atherosclerosis, a chronic vascular disease accounts for major deaths worldwide. 
Associations between atherosclerosis and periodontitis have been documented by 
epidemiological studies. The process underlying P. gingivalis (Pg) infection induced 
atherogenesis however, is unclear. Macrophage ‘foam cells’ formation is a hallmark for in-
vivo atherosclerosis progression. Our studies indicate that a calcium channel, Transient 
Receptor Potential channel of the vanilloid family 4 (TRPV4) mediates foam cell 
generation on Pg lipopolysaccharide (PgLPS) stimulation. Also, we observed increased 
TRPV4 activity (Ca2+ influx) with PgLPS treatment. Genetic deletion of TRPV4 or 
inhibition by TRPV4 specific chemical antagonist impeded PgLPS-triggered aggravated 
oxidized LDL (oxLDL) uptake and foam cell formation. Our results mechanistically 
showed that i) TRPV4 is required for oxLDL uptake, but not its cell surface binding ii)   
Decreased foam cell formation is independent of CD36 expression.  Altogether, our results 
demonstrate that TRPV4 plays a crucial role in PgLPS-induced exacerbation of oxLDL-
mediated macrophage foam cell formation.
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Chapter 1: Introduction 
A chronic arterial disease, atherosclerosis, is one of the leading causes of death 
throughout the world [1-4] Cardiovascular disease (CVD) is characterized by 
atherosclerosis as the underlying pathology. 17.9 million lives are lost each year due to 
CVD, contributing to 31% of worldwide deaths [70]. Despite accounting for the 
massive loss of lives, the molecular mechanisms of this disease are not well understood. 
A defining event in atherogenesis initiation and progression is macrophage 
foam cell formation [1]. Macrophagic recognition and ingestion of oxidized low-
density lipoproteins (oxLDL) is believed to be a critical pathogenic occurrence in 
atherogenesis [3]. Monocytic scavenger receptor such as CD36 has a crucial role in the 
uptake of oxLDL leading to foam cell formation [4, 5]. However, several discrepancies 
have been reported in scavenger receptor mediated foam cell formation, suggesting 
additional mechanisms in this process. 
Origination of reactive oxygen species (ROS) and heightened oxidative stress 
has been distinctly associated with atherosclerosis [1-7]. The surface of LDL particles 
is oxidized by increased ROS production to generate oxLDL which causes its 
endocytosis by scavenger receptors like CD36 [3-5]. Internalization of oxLDL may 
also increase ROS generation in a positive feedback loop, ultimately leading to 
atherosclerotic lesion progression[1-7]. 
Macrophage differentiation, apoptosis, adhesion, proliferation, migration and 
inflammatory response is mediated by Ca2+ signalling (48, 49). Atherosclerotic lesion 





Potential channel subfamily Vanilloid member 4 (TRPV4) is a cation channel 
ubiquitously expressed in a variety of cells including macrophages (56-64, 40-47). 
Recent finding from others as well as our group has shown TRPV4 to be allied with 
various cellular and pathological conditions (40-47, 56-64). 
Association between periodontitis and atherosclerosis has been correlated by 
epidemiological studies (17-22). Despite limiting the traditional cardiovascular disease 
(CVD) risk factors, atherogenesis in animal models has been linked to P. gingivalis 
spawned periodontitis infection (23-26). However, the mechanisms underlying 
periodontitis induced atherosclerosis is not clearly defined. Thus, we hypothesize that 
TRPV4 has an essential function in regulating PgLPS mediated foam cell formation. 
The objective of this study was to test the role of TRPV4 calcium channel 
in P. gingivalis-induced exacerbation of oxidized LDL-mediated macrophage 
foam cell formation. To investigate the role of this calcium channel we have carried 
out several in vitro and in vivo experiments utilizing bone marrow derived murine 
macrophages, resident murine macrophages, macrophage cell lines (RAW cells).  We 
made several key observations: i) our findings elucidated that PgLPS induced 
exacerbation of oxLDL mediated foam cell formation is TRPV4 dependent; ii) PgLPS 
influenced TRPV4 specific calcium influx is dependent on matrix stiffness; iii) 
Treatment of PgLPS causes increased expression of TRPV4 protein; and iv) Foam cell 








Chapter 2: Literature Review 
Atherosclerosis represents the predominant cause underneath heart disease and 
stroke. Early lesions of atherosclerosis are characterized by endothelial dysfunction 
followed by cholesterol rich low-density lipoprotein (LDL) retention [1, 2]. 
Inflammation in the arterial intima causes oxidation of LDL (oxLDL). Scavenger 
receptor such as CD36 present on the surface of macrophages recognizes these 
modified LDL and subsequent engulfment ensues, resulting in “lipid-loaded 
macrophage foam cell” [1, 3]. Continuous deposition of foam cells, calcium, necrotic 
debris and cellular waste products leads to atheroma progression and ultimately 
culminates in development of atherosclerosis related vascular pathologies [3, 6, 7].  
A variety of inflammatory secretions generating from macrophages makes them 
critical regulators of atherogenesis [3, 4]. In previous studies it has been shown that a 
distinctive feature of atherosclerotic murine model is macrophagic proliferation and 
accumulation in advanced lesions [8]. Decrease in foam cell formation or reduced 
oxLDL uptake in mice has been attributed to CD36 or SR-A deficient macrophages [9-
12]. Nonetheless, several discrepancies have been reported regarding the role of 
scavenger receptors in atherosclerosis [13]. ApoE knock out mice for example lacking 
CD36 or SR-A resulted in an increased risk of atherosclerosis and foam cell formation 
[14]. Altogether, these reports indicate complex nature of atherogenesis and also 
suggest that additional mechanisms may be involved in atherosclerotic lesion 
development and progression.  
Chronic inflammation coupled by oxidative environment escalates the 





oxidative stress. Atherogenesis and oxidative stress has been distinctly correlated [1-
7]. Increased ROS production causes heightened generation of oxidized phospholipids 
on the surface of LDL particles forming atherogenic oxLDL which is specifically 
recognized and internalized by macrophages with the help of SR-A and CD36 [3, 5]. 
Heightened ROS production and oxLDL uptake may cause mitochondrial damage 
leading to apoptosis in macrophages as well as necrotic core formation [1-7]. 
Recent studies have suggested that P. gingivalis infection might be associated 
with atherosclerosis [15-26]. Nearly 100 million people are affected in the United 
States by periodontitis [17-22]. Despite controlling traditional risk factors of 
Cardiovascular disease (CVD), associations between periodontitis and atherosclerosis 
have been supported by epidemiological studies and animal models [17-22]. Arterial 
stiffness and periodontitis have been linked in other studies as well [27-31]. 
Macrophages can directly interact with their surrounding mechanical environment [32-
38]. Interestingly, bacterial LPS is shown to increase macrophage rigidity and vascular 
stiffness [35, 39]. 
Various macrophagic functions such as apoptosis, cell differentiation, adhesion, 
proliferation, migration and inflammation involve Ca2+ signalling [40, 41]. Increased 
calcium influx is identified with atherosclerotic lesion generation, macrophage foam 
cell formation and phagocytosis [42-44]. Several channels are present in macrophages 
to regulate Ca2+ homeostasis [45]. 
Ca2+ permeable membrane channel, TRPV4, is ubiquitously expressed in 
various cells including macrophages [45-53]. TRPV4 has been linked to various 





also been linked to eNOS activation in endothelial cells, as well as preventing 
monocyte adhesion to these cells, suggesting an atheroprotective role [50]. Increased 
occurrence of endothelial dysfunction and vascular disease is observed with impaired 
TRPV4 channel [51, 54, 55]. In this study we demonstrate that Porphyromonas 
gingivalis LPS-induced increase in oxLDL uptake and macrophage foam cell formation 






Chapter 3: Research Objectives 
Epidemiological studies have shown that there is a link between 
Porphyromonas gingivalis (Pg) infection, causative agent of Periodontitis and 
Atherosclerosis. However, it is not well known how Pg infection advances this 
cardiovascular disease. Here, we have elucidated the role of TRPV4 calcium channel 
in Pg-induced macrophage foam cell formation, a critical process in atherogenesis. 
Research Aims 
1. Examine whether P. gingivalis lipopolysaccharide-induced oxLDL mediated 
macrophage foam cell formation is reliant on TRPV4. 
 
2. To determine TRPV4-dependent Ca2+ influx in response to P. gingivalis 
lipopolysaccharide. 
 
3. Investigate if lack of foam cell formation in TRPV4 deficient cells is due to 
lack of expression of CD36. 
 
4. Determine if TRPV4 protein expression is modulated by PgLPS treatment. 
 
5. Determine whether TRPV4 is required for oxLDL uptake. 
 
Impacts 
TRPV4 has been indicated as a novel plasma membrane Ca2+ channel involved 
in foam cell formation, a critical event in atherosclerosis. Comprehending the 
underlying pathology of periodontitis fostered atherosclerosis, might assist us in 
uncovering disease pathogenesis mechanisms and assessing fatalities. Hence, these 
findings can have a major impact in the discovery of selective therapeutics to reduce 





Chapter 4: Materials and methods 
Cell culture and Animals: 
TRPV4 knockout (TRPV4KO) mice had been originally generated by Dr. 
Suzuki (Jichi Medical University, Tochigi, Japan) on C57BL/6 [52] and given to us by 
Dr. Zhang (Medical College of Wisconsin, Milwaukee, WI). Congenic Wild Type 
(WT) C57BL/6 mice were bought from Charles River Laboratories (Wilmington, 
Massachusetts, USA). Animal experimentation were conducted by guidelines issued 
by Institutional Animal Care and Use Committee and approved by University of 
Maryland review committee. Previously described protocols [12, 56] were followed to 
collect Murine Resident Macrophages (MRM) and Bone Marrow Derived 
Macrophages (BMDMs). PBS was injected into mouse peritoneal cavity to collect 
MRMs. Bone Marrow cells yielded BMDMs by harvesting the cells in RPMI1640 
media with M-CSF supplementation for 7-8 days and incubated at 37oC and 5% CO2. 
Agonists, Antagonists, Antibody and Reagents:  
TRPV4 agonist GSK1016790A (GSK101) and antagonist GSK2193874 
(GSK219), DiI (1,1’-Dioctadecyl-3,3,3’,3’-tetramethylindocarbocyanine perchlorate) 
and calcium ionophore A23187 (A23) were purchased from Sigma-Aldrich (St. Louis, 
MO, USA). TRPV4 antibody were obtained from Alomone Labs (Jerusalem, Israel) 
and anti-β-actin antibody was supplied by Santa Cruz Biotechnology (Dallas, TX, 
USA). CD36 antibody was purchased from BD Pharmingen. LDL was incubated with 
CuSO4 (5µM) for 12h at 37
oC to produce copper-oxidized LDL (oxLDL) [12]. 





Devices (Sunnyvale, CA, USA) provided us FLIPR Calcium 6 assay kit. Western Blot 
Reagents were bought from Bio-Rad Laboratories (Hercules, CA, USA). RPMI1640 
media as well as other cell culture reagents were purchased from Gibco. Varying 
stiffness (0.5-50 kPa) easy coat polyacrylamide hydrogels had been obtained from 
Martigen Life Technologies (Brea, CA, USA). InvivoGen (San Diego, CA, USA) was 
the manufacturer of PgLPS.   
Intracellular Calcium measurement:  
Measurement of calcium influx responses in BMDM cells was done with 
FLIPR 6 Calcium Assay Kit. Collagen coated 96 well clear bottomed plates with 10% 
serum containing RPMI media and 25 ng/ml M-CSF were used for seeding cells. 6-7 
days were given for cellular differentiation and adherence. Media was changed to 0.5% 
serum containing RPMI and 500ng/ml PgLPS to appropriate wells. After incubation 
for 24hours, cells were again incubated for 90 minutes in FLIPR Calcium 6 dye in 1X 
HBSS, 20mM HEPES (pH 7.4) and 2.5 mM probenecid. GSK101 was used as a 
specific TRPV4 agonist (increasing cytosolic calcium) and GSK219 was used as 
TRPV4 antagonist. Relative Fluorescence Unit (RFU) was used as a means of 
measuring cytosolic Ca2+ influx [57-59]. 
Foam Cell Assay: 
WT and TRPV4KO MRMs were seeded on collagen coated (10µg/ml) glass 
coverslips (in 12 well plates) or on polyacrylamide hydrogels of varying stiffness 
(0.5kPa and 8kPa). Cells were incubated for 48 hours in 10% serum containing RPMI. 





presence or absence of 500ng/ml PgLPS followed by 20 hours of incubation [57-59]. 
Cells were fixed using 10% formalin for 10 minutes and stained with Oil Red O and 
counted by Zeiss Axio Observer (40x) microscope [12, 58].     
Western Blot Analysis: 
BMDM cells incubated in the presence or absence of PgLPS (0, 250, 1000 
ng/ml) for 48 hours were washed with ice cold PBS and lysis buffer composed of 
20mM Tris-HCL (pH 7.5), 1mM EGTA, 1mM EDTA, 150mM NaCl, 2.5mM sodium 
pyrophosphate, 1mM β-glycerophosphate, 1% NP-40, 1mM NP-40, 2.5mM Na4P2O7 
1µg leupeptin and 1mM Na3VO4 [12]. Same amounts of protein lysate were resolved 
in a 10% SDS-polyacrylamide gel and transferred to a polyvinylidene difluoride 
membrane which was probed with TRPV4 and CD36 antibodies. Signals were detected 
using an ECL kit (Thermo Fischer Scientific) and quantified using Image J software.  
Real Time quantitative polymerase chain reaction (qRT-PCR): 
RNeasy Micro Kit (Qiagen) was used to extract total RNA from WT and 
TRPV4KO cells. One step qRT-PCR analysis done by QuantiNova SYBR Green qRT-
PCR Kit (Qiagen). Following the manufacturer’s instructions, qRT-PCR was 
performed using TRPV4, CD36 and GAPDH primers (TaqMan gene expression assay, 
Applied Biosystems). TRPV4 and CD36 expression was measured as the amount of 
TRPV4 or CD36 relative to mRNA for GAPDH by comparative CT method outlined 






For investigating uptake assay, MRMs were seeded on glass coverslips in the 
presence or absence of 500ng/ml PgLPS and incubated with DiI-labeled oxLDL (DiI-
oxLDL) (5µg/ml) at 37oC for 30 minutes[12, 44, 56]. Zeiss Axio Observer Microscope 
(63x) used to visualize fluorescence. Quantification done through ImageJ software. 
Statistical Analysis: 
All data are represented as mean ± SEM. Statistical comparison experimental 
and control groups were performed using Student’s t-test or ANOVA using SigmaPlot 






Chapter 5: Results 
PgLPS-induced oxLDL mediated macrophage foam cell formation is 
reliant on TRPV4 
Ca2+ signalling is vital in macrophage foam cell formation [36, 42-44]. Gram 
negative bacterial outer membrane is composed of highly inflammatory 
lipopolysaccharide (LPS) molecules that induce Ca2+ influx and generate foam cells 
[60-62]. Our hypothesis was TRPV4 might be involved in PgLPS influenced ingestion 
of oxLDL to form foam cell. We tested our hypothesis by comparing foam cell 
formation in TRPV4 KO and WT MRMs with or without PgLPS. A 4-fold increase in 
foam cell generation was observed in oxLDL-treated versus nLDL (native LDL)-
treated WT MRMs (Fig. 1A & B). PgLPS and oxLDL when administered together 
compounded foam cell production with respect to untreated controls (Fig. 1A & B). 
Genetic deletion of TRPV4 significantly reduced macrophage foam cell formation, 
irrespective of oxLDL treatment alone or in combination with PgLPS (Fig. 1A & B). 
Pharmacological inhibition of TRPV4 channel by GSK219 reduced foam cell 
formation (Fig. 2A & B). These results correlate TRPV4 as a critical player in PgLPS-






Figure 1. PgLPS-induced oxLDL mediated macrophage foam cell formation is reliant on 
TRPV4. (A) Murine resident macrophages from WT and TRPV4 KO mice were isolated and 
incubated for 48 hours in the presence or absence of PgLPS (500ng/ml), followed by a 
subsequent 20 hours incubation with native low-density lipoproteins (nLDL, 50µg/ml) or 
oxidized low-density lipoprotein (oxLDL, 50µg/ml). Macrophage foam cell formation was 
measured by fixing the cells and staining them with Oil Red O.  Representative images shown 
were obtained from five different fields per condition (40X original magnification). Results 
expressed as mean ± SEM. ***p<0.001 for oxLDL treated WT vs TRPV4 KO cells with 
PgLPS, **p<0.01 for oxLDL treated WT vs TRPV4 KO cells and *p<0.05 oxLDL treated vs 
untreated WT cells without PgLPS; n = 500 cells per condition (B) Results quantified from 1A.  
 
 
A                                                                     B 
 
 
Figure 2. PgLPS-induced oxLDL mediated macrophage foam cell formation is inhibited 
by TRPV4-specific inhibitors. (A) Cells were cultured similarly as above and treated with 
TRPV4 specific antagonist, GSK219 and nLDL (50µg/ml) or oxLDL (50µg/ml). Oil Red O 
stained cells. Representative images shown were obtained from five different fields per 
condition (40X original magnification). (B) Results quantified from 2B. Results expressed as 
mean ± SEM. ##p<0.001 for oxLDL, PgLPS and GS219 treated cells vs oxLDL and PgLPS 
cells, **p<0.01 for oxLDL treated vs oxLDL plus GSK219 treated cells and *p<0.05 for 





TRPV4 dependent Ca2+ influx is induced by PgLPS and dependent on 
matrix stiffness 
TRPV4 specific agonist GSK101 was used to measure Ca2+ influx in BMDMs 
in presence or absence of PgLPS [53]. We observed increased influx of Ca2+ in PgLPS 
treated cells in comparison to untreated cells. (Fig. 3A & B). TRPV4 KO BMDMs on 
the other hand did not show Ca2+ influx. GSK101 induced Ca2+ however, was blocked 
by GSK219, a TRPV4 selective antagonist in PgLPS treated BMDMs [53] (Fig. 4A). 
These observations indicate that the loss of TRPV4 function either by pharmacological 
inhibition or genetic deletion blocks PgLPS induced Ca2+ influx. Our results also 
showed that PgLPS induced TRPV4 channel activity was increased on increasing the 
matrix stiffness when BMDMs were plated on stiffer matrices (1-25kPa). However, 
TRPV4 KO cells showed abrogated Ca2+ influx (Fig. 4B). These data confirm the 
induction of TRPV4 specific Ca2+ influx on effect of PgLPS and matrix stiffness. 
 
 
Figure 3. TRPV4 dependent Ca2+ influx is induced by PgLPS. (A) BMDMs loaded with 
Calcium 6 dye, showing effect of GSK101 (10nM) on Ca2+ influx in TRPV4Ko and WT cells 
in the presence or absence of PgLPS. (B) Results quantified from 3A. *p<0.05 for PgLPS 









A                                                                B 
 
Figure 4. TRPV4 dependent Ca2+ influx is induced by PgLPS and dependent on matrix 
stiffness. (A) Blocking PgLPS induced Ca2+ influx by TRPV4 specific GSK219. *p<0.05 for 
PgLPS treated WT vs untreated WT cells, ###p<0.001 for PgLPS treated WT vs PgLPS plus 
GSK219 treated WT cells. (B) TRPV4 KO and WT MRMs were plated on variable stiffness 
(1, 8 and 25kPa) hydrogels. GSK101 (10nM) mediated Ca2+ influx was assessed. **p<0.01 for 
soft (1kPa) vs stiff (8kPa and 25kPa) hydrogel grown cell, ***p<0.001 for WT vs TRPV4 KO 
cells grown on 25kPa hydrogels. A23187 (A23) is a non-specific Ca2+ calcium ionophore. 
Experiments were replicated three times. 
 
CD36 expression does not play a role in decreased foam cell formation 
in TRPV4 absent cells 
CD36 is considered to be a major scavenger receptor involved in macrophage 
foam cell formation. Thus, we tested the expression levels of CD36 by qRT-PCR and 
western blot analysis in WT and TRPV4Ko macrophages. Expression levels of CD36 
mRNA as well as CD36 protein were equal in WT and TRPV4 KO cells which were 






Figure 5. CD36 expression does not play a role in decreased foam cell formation in TRPV4 
absent cells. (A) CD36 expression level in WT and TRPV4 KO MRMs determined by qRT-
PCR analysis. TaqMan Gene Expression Assay used. CT values normalized to GAPDH. (B) 
CD36 protein expression was shown by representative immunoblots from three independent 
experiments conducted in WT MRMs in the presence or absence of PgLPS treatment. Actin 
was used as loading control.  
 
 
TRPV4 protein expression is increased with increased PgLPS stimulation 
TRPV4 expression level was measured to deduce the role of TRPV4 in 
macrophage foam cell formation. We observed similar TRPV4 mRNA expression 
levels in the presence or absence of PgLPS for 24 hours (Fig. 6A). Protein expression 
of TRPV4 was increased with PgLPS treatment in a dose dependent manner (Fig. 6B 
& C).    
 
Figure 6. TRPV4 protein expression is increased with increased PgLPS stimulation. (A) 
TRPV4 levels in WT MRMs with or without PgLPS were measured by qRT-PCR analysis 
using TaqMan Gene Expression Assay. CT values normalized to GAPDH. (B) TRPV4 protein 
expression depicted by representative immunoblots from three independent experiments 





control. (C) Quantification of results from 6B. Results expressed as mean ± SEM. *p<0.05 for 




Macrophage oxLDL uptake is TRPV4 dependent 
A      Untreated               PgLPS         PgLPS+GSK219       B 
 
Figure 7. Macrophage oxLDL uptake is TRPV4 dependent. (A) MRMs isolated from WT 
and TRPV4 KO mice were incubated with DiI labelled oxLDL (5µg/ml) at 37oC for 30 minutes. 
Representative images shown were obtained from five different fields per condition (40X 
original magnification). Uptake of oxLDL was measured by red fluorescence. (B) 
Quantification results from 7A depicted by bar graph showing mean DiI fluorescence intensity 
(mean ± SEM) (ImageJ software, NIH). **p<0.01 for TRPV4 KO vs WT untreated cells, 
##p<0.01 for PgLPS treated WT vs WT untreated cells, ***p<0.001 for PgLPS treated WT vs 








Chapter 6:  Discussion 
The results of this study concluded that i) macrophage foam cell formation by 
PgLPS stimulation is reliant on TRPV4; and ii) PgLPS treatment increases TRPV4-
mediated Ca2+ influx in a matrix stiffness dependent manner. We also showed that i) 
decreased foam cell formation in TRPV4 deficient cells is independent of CD36 
expression; and ii) increased PgLPS stimulation increases TRPV4 protein expression. 
In addition, we demonstrated that oxLDL uptake in PgLPS-treated macrophages is 
dependent on TRPV4. 
Individuals with chronic periodontal disease have the immunomodulatory 
molecule Porphyromonas gingivalis lipopolysaccharide present in their blood stream.  
Prior findings have reported that PgLPS exposure augments binding and uptake of 
oxidized LDL, initiates macrophage foam cell formation, leads to M1 macrophage 
infiltration and macrophage regulated inflammation in the affected tissues [15-26, 62]. 
Our group and others previously have shown an association between foam cell 
formation in macrophages and oxLDL uptake [12, 43, 44]. A variety of cellular 
processes are governed by Ca2+, including macrophage phagocytosis and foam cell 
formation [42, 44]. Studies have shown that Ca2+ influx and foam cell formation is 
aggravated by oxLDL [42, 44]. These effects however, were negated by non-specific 
Ca2+ channel inhibitors [44, 59, 63]. Recently, we demonstrated the requirement of 
TRPV4 in oxLDL mediated macrophage foam cell formation [58]. This current study 
specifically addresses role of TRPV4 in PgLPS and matrix stiffness-mediated 





TRPV4 has been documented to have an atheroprotective role whereby, the 
channel activation inhibits monocyte adhesion and causes eNOS activation in 
endothelial cells [50]. On the other hand, TRPV4 channel mis regulation has been 
linked to reduced macrophage foam cell generation, vascular diseases and endothelial 
dysfunction [51, 54, 55, 58]. Yet, the mechanism underlying TRPV4-mediated 
macrophage foam cell formation by PgLPS stimulation is not known. This study 
discovered that TRPV4 protein expression and Ca2+ intake is increased with increased 
PgLPS stimulation. TRPV4 dependent calcium influx activity was increased on 
exposure of PgLPS to cells in a matrix stiffness-dependent manner. Our findings are 
consistent with a previous report showing sensitivity of macrophage inflammatory 
responses to matrix stiffness [36]. We have also shown that uptake of oxLDL is TRPV4 
dependent. Pharmacological inhibition (GSK219) or genetic deletion of TRPV4 
(TRPV4 KO) nullifies calcium intake and oxLDL internalization when BMDMs are 
grown on a stiff matrix substrate. 
TRPV4 cation channel is expressed ubiquitously in different cell types. Activity 
of this protein is influenced by numerous biological and mechanical stimulus [46-53, 
55, 57-59, 64-67]. TRPV4 deficient mice have been reported to have various 
pathological conditions including abnormal osmosensing, bone development, 
vasodilatory responses and lung edema [46-53, 55, 57-59, 64-67]. Our group has shown 
that TRPV4 null mice are protected from lung and skin fibrosis induced by bleomycin 
[57, 68]. In another study LPS treatment has been linked to increasing stiffness of lung 
tissue in mice [39]. Combined clinical and experimental data indicates a connection 





atherogenesis have pointed out the critical role of mechanical factors, e.g. matrix 
stiffness, and biochemical factors (lipopolysaccharide, LPS) in disease development 
and progression [27-38, 69]. These results put forward a potential mechanism to 
augment TRPV4 activity during PgLPS influenced atherogenesis. 
Previously, results from our laboratory and others showed matrix stiffness 
induces several atherogenic macrophagic functions such as motility, proliferation and 
phagocytosis [32-38]. The current study has identified TRPV4, a plasma membrane 
Ca2+-permeable channel as having a crucial role in regulating pro-atherogenic 
responses associated with pathogenesis of periodontitis-induced atherosclerosis. 
Additional studies however, are required for understanding the exact mechanisms 
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